Seeking Alpha


Send Message
View as an RSS Feed
View richwillard's Comments BY TICKER:
Latest  |  Highest rated
  • Venaxis rallies, Craig-Hallum reportedly sees big upside [View news story]
    Finally someone gets it.
    Nov 26, 2013. 01:08 AM | Likes Like |Link to Comment
  • Horizon Pharma Continues Cash Burn And Dilution [View article]
    Let's see,I've already doubled my initial investment in HZNP since March, including a good trade on the volatility recently. I have long term and trading shares, this has been for me as good as it gets. I agree with Postbusters, TW has what it takes to deliver shareholder value, long term and with capital raises at appropriate times. I admire a well run company and vote with my shares, this one is a keeper, added more today on the sudden weakness, what we call consolidation. I hope you took the opportunity to cover your short and that you are done with shorting such a bullish name!
    Nov 12, 2013. 01:17 AM | Likes Like |Link to Comment
  • Undervalued Questcor Is Setting Up For A Significant Upswing In Share Price [View article]
    I bought shares after reading your article at 55.95 per share, and today it closed at 68.40. Message boards are lighted up with bullish posts about a quarterly earnings beat next week and $15 surge in the stock price. I am very happy to have read your well timed article. I did see the chart and figured it was a perfect buying opportunity when it closed the gap left open. I only wish now that I had taken a bigger position. This looks like a good one to hold long term, it could top $100 in the next four months at this rate.
    Oct 26, 2013. 02:21 AM | Likes Like |Link to Comment
  • Has Horizon Pharma's Share Price Bottomed Out? [View article]
    What a brilliant article and a perfect time for people to grab the stock at bargain prices and watch it fly!! Looking back now at the comments, I see if William LeGros held his shares he's happy now. MoFisher likely is still holding and he had a boatload of shares. I had 8,000 shares and have now doubled my investment, but took some profits awaiting a pullback on a portion of my shares. Want to go in heavier as I think there's a lot of room to run, it has outperformed my other holdings. Wouldn't you know I didn't overweight this one, but will going forward. TW is the best CEO and not enough credit is being given to his leadership.
    Oct 26, 2013. 02:15 AM | Likes Like |Link to Comment
  • Antares Pharma's Otrexup Will Gain FDA Approval And Generate Positive EPS [View article]
    So Michael, you must have sold out on October 14th? Why don't you do Part 2 of: Why has Antares Pharma Fallen so Sharply? It's a bit better than if they got the CRL, I suppose, only we know it will fight its way back up over $5 before too long, then from there is dependent on news and earnings.
    Oct 24, 2013. 12:33 AM | Likes Like |Link to Comment
  • ChemoCentryx: Upcoming Phase III Data Readout To Catalyze Shares [View article]
    If you liked CCXI at $14 a share in August, and it's now selling at $5.34, how do you like it now? I hold no shares but am looking at opening a position in the stock. What went horribly wrong, that is what I will look at next, before I invest. I have just looked at BVF Investments having purchased 1,724,414 shares in the last 40 days at an average price of $5.46 a share. They obviously like it, and they have done pretty well, they are showing a 6-month average return of around 30% on their buys and sells so far this year.
    Oct 19, 2013. 11:20 PM | Likes Like |Link to Comment
  • BioSante's Reverse Split Equals Shareholder Dilution [View article]
    And here we are today ANIP is $0.02 away from $11 a share and on October 7th eclipsed $12 a share. Let's hope Libigel is brought forward to see its full potential realized by ATRS shareholders alike, where the drug originated. Go ANIP! As to you Mr. Stocklaser, you were a flash in the pan on the ATRS message boards last summer and then all of a sudden, you're gone! POOF! Good luck to ANIP shareholders. Don't listen to the naysayers, never say die!
    Oct 16, 2013. 12:56 AM | Likes Like |Link to Comment
  • Antares Pharma Inc- FDA Approval With A Hint Of Adam F Manipulation [View instapost]
    I absolutely loved reading your article, thank you for writing it today! I am absolutely dumbfounded by how someone like AF would put such a trash piece out for consumption by the masses, especially when there are a lot of very intelligent people who invest in these bio stocks, who know way more than he does. He is like you said, "doing a great job" of trashing his own credibility by throwing insults at the community's intelligence. You have a nice style of writing, and for you to be able to put this together the same day in such a tight and readable fashion, is a testament to your skill and intelligence as an author. Keep writing!
    Oct 14, 2013. 08:58 PM | 2 Likes Like |Link to Comment
  • Cytokinetics jumps as Needham reiterates omecamtiv bull thesis [View news story]
    You made a good call. Oversold CYTK will yield to strength in recovery and longs will have their turn. Staying too long can cause one to give it back, no?
    Oct 12, 2013. 01:49 AM | 1 Like Like |Link to Comment
  • An Expanding Distribution Infrastructure Augurs Well For Atossa Genetics [View article]
    I sold 20% of my position today at a huge loss. Until we get something out of the Company, which may not come for months, this stock is very vulnerable to trash talk and downside movement. Meanwhile, I have some other companies on my radar that look like sure things going forward with strong upcoming catalysts. It is difficult to decide whether this one is going to make a comeback, and whether their distributors will keep faith and stay in their deals. I read that only 10% of their test kits had actually been shipped to distributors, so the cost of the recall is just in the damage to the company and it's stock, not so much a big expense to recall. No revenues though, and no other products being touted with distribution dates set. It's a tough call, a miserable set of circumstances, and I am very torn as to what to do. There's so little available information, I don't know if Aspire has an escape hatch but if they do, they will exercise it. Their loss is huge at this point, they bought some very expensive shares to begin.
    Oct 11, 2013. 09:37 PM | Likes Like |Link to Comment
  • Catalyst Pharmaceutical Partners: A Compelling Pipeline For Long-Term Growth [View article]
    The day your article appeared the stock was at $1.25 a share. I just looked today and it closed last week at $3.28 per share. I would say you made a good call and those who acted by taking a position shortly after your article easily doubled their money in a few months. Good job, what is the next call?
    Oct 7, 2013. 02:37 AM | Likes Like |Link to Comment
  • After-hours top gainers / Losers, as of 5:15 p.m [View news story]
    Halo didn't trade down after hours. Bad information!
    Sep 28, 2013. 05:28 PM | 1 Like Like |Link to Comment
  • Alexza's EU Partner (Grupo Ferrer) Signs New ADASUVE Deal With Medivir [View instapost]
    Another well researched article, lest investor's forget what has come before them, and up to the present day, they do continue to execute. It seems the only thing that is stuck is the price of the shares, everything else is proceeding nicely.
    Sep 24, 2013. 01:28 AM | 1 Like Like |Link to Comment
  • BioSante's Reverse Split Equals Shareholder Dilution [View article]
    I held my shares and am now close to break even after the nearly doubling of the share price since the reverse split. Further, look at what has happened with NBS since their reverse split just a couple of months ago, it has nearly doubled as well. You can't make broad sweeping generalizations on these biotechs as regards R/S.
    Sep 23, 2013. 02:22 PM | Likes Like |Link to Comment
  • Examining Inovio: Impact Of Roche Deal [View article]
    You write a balanced piece and we thank you for covering this dynamic company that has entered a new era with this Roche deal. You do make one error which is the date that Inovio made their deal with Roche. September 10th, not August 10th. Nobody was offended or even noticed, but I thought you should know.
    Sep 11, 2013. 11:29 PM | Likes Like |Link to Comment